Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Yasuhiko Hattori"'
Autor:
Atsuhito Uneda, Kazuhiko Kurozumi, Atsushi Fujimura, Kentaro Fujii, Joji Ishida, Yosuke Shimazu, Yoshihiro Otani, Yusuke Tomita, Yasuhiko Hattori, Yuji Matsumoto, Nobushige Tsuboi, Keigo Makino, Shuichiro Hirano, Atsunori Kamiya, Isao Date
Publikováno v:
Acta Neuropathologica Communications, Vol 9, Iss 1, Pp 1-23 (2021)
Abstract Glioblastoma (GBM) is the most lethal primary brain tumor characterized by significant cellular heterogeneity, namely tumor cells, including GBM stem-like cells (GSCs) and differentiated GBM cells (DGCs), and non-tumor cells such as endothel
Externí odkaz:
https://doaj.org/article/a0638dbbb3624887941a84049bd7896b
Autor:
Motomasa Furuse, Hiroko Kuwabara, Naokado Ikeda, Yasuhiko Hattori, Tomotsugu Ichikawa, Naoki Kagawa, Kenichiro Kikuta, Sho Tamai, Mitsutoshi Nakada, Toshihiko Wakabayashi, Masahiko Wanibuchi, Toshihiko Kuroiwa, Yoshinobu Hirose, Shin-Ichi Miyatake
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background The prevalence of programmed death-ligand 1 (PD-L1) and PD-L2 expression on tumor cells and tumor-infiltrating immune cells in primary central nervous system lymphoma (PCNSL) remains unclear. In the present study, we analyzed need
Externí odkaz:
https://doaj.org/article/739ac5ffd30b4c9aaf0c973677d44c6b
Autor:
Yuji Matsumoto, Tomotsugu Ichikawa, Kazuhiko Kurozumi, Yoshihiro Otani, Atsushi Fujimura, Kentaro Fujii, Yusuke Tomita, Yasuhiko Hattori, Atsuhito Uneda, Nobushige Tsuboi, Keisuke Kaneda, Keigo Makino, Isao Date
Publikováno v:
Acta Neuropathologica Communications, Vol 8, Iss 1, Pp 1-13 (2020)
Abstract Glioblastoma (GBM) is characterized by extensive tumor cell invasion, angiogenesis, and proliferation. We previously established subclones of GBM cells with distinct invasive phenotypes and identified annexin A2 (ANXA2) as an activator of an
Externí odkaz:
https://doaj.org/article/6c761b1949624b2696f149d55408b8a8
Autor:
Yasuhiko Hattori, Kazuhiko Kurozumi, Yoshihiro Otani, Atsuhito Uneda, Nobushige Tsuboi, Keigo Makino, Shuichiro Hirano, Kentaro Fujii, Yusuke Tomita, Tetsuo Oka, Yuji Matsumoto, Yosuke Shimazu, Hiroyuki Michiue, Hiromi Kumon, Isao Date
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0273242 (2022)
Reduced expression in immortalized cells/Dickkopf-3 (REIC/Dkk-3) is a tumor suppressor and its overexpression has been shown to exert anti-tumor effects as a therapeutic target gene in many human cancers. Recently, we demonstrated the anti-glioma eff
Externí odkaz:
https://doaj.org/article/60c3b1065683424a95b1b96535ea3c5a
Autor:
Yoshihiro Otani, Joji Ishida, Kazuhiko Kurozumi, Tetsuo Oka, Toshihiko Shimizu, Yusuke Tomita, Yasuhiko Hattori, Atsuhito Uneda, Yuji Matsumoto, Hiroyuki Michiue, Shuta Tomida, Takehiro Matsubara, Tomotsugu Ichikawa, Isao Date
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
Abstract Despite therapeutic advances, glioblastoma represents a lethal brain tumor. Recently, research to identify prognostic markers for glioblastoma has intensified. Our previous study demonstrated that median progression-free survival (PFS) and o
Externí odkaz:
https://doaj.org/article/3e7ede37e22043e69e63784956e3a78e
Autor:
Isao Date, Balveen Kaur, Tetsuo Oka, Yoshihiro Otani, Toshihiko Shimizu, Yasuhiko Hattori, Atsuhito Uneda, Yuji Matsumoto, Tomotsugu Ichikawa, Kentaro Fujii, Ji Young Yoo, Kazuhiko Kurozumi, Yusuke Tomita
Supplementary Figure 2 shows In vitro scratch migration assay.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a626091dd422e0d16a65ebd5ea7875c2
https://doi.org/10.1158/1535-7163.22505842
https://doi.org/10.1158/1535-7163.22505842
Autor:
Isao Date, Yuji Matsumoto, Atsuhito Uneda, Yasuhiko Hattori, Yusuke Tomita, Tetsuo Oka, Yoshihiro Otani, Tomotsugu Ichikawa, Kazuhiko Kurozumi, Joji Ishida, Toshihiko Shimizu
Glioma cell cytotoxicity with bevacizumab treatment in vitro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12306c9163a888bd3341722dd04a236f
https://doi.org/10.1158/1535-7163.22505580
https://doi.org/10.1158/1535-7163.22505580
Autor:
Isao Date, Balveen Kaur, Tetsuo Oka, Yoshihiro Otani, Toshihiko Shimizu, Yasuhiko Hattori, Atsuhito Uneda, Yuji Matsumoto, Tomotsugu Ichikawa, Kentaro Fujii, Ji Young Yoo, Kazuhiko Kurozumi, Yusuke Tomita
Supplementary Figure 3 shows Full scans of the western blotting shown in the figure 6.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::117ca56e67bd182fcc74fa2dc37cfd05
https://doi.org/10.1158/1535-7163.22505839.v1
https://doi.org/10.1158/1535-7163.22505839.v1
Autor:
Isao Date, Yuji Matsumoto, Atsuhito Uneda, Yasuhiko Hattori, Yusuke Tomita, Tetsuo Oka, Yoshihiro Otani, Tomotsugu Ichikawa, Kazuhiko Kurozumi, Joji Ishida, Toshihiko Shimizu
Bevacizumab increased the rate of wound closure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fb0b1b59b57133ad28d969a29138654
https://doi.org/10.1158/1535-7163.22505577
https://doi.org/10.1158/1535-7163.22505577
Autor:
Isao Date, Yuji Matsumoto, Atsuhito Uneda, Yasuhiko Hattori, Yusuke Tomita, Tetsuo Oka, Yoshihiro Otani, Tomotsugu Ichikawa, Kazuhiko Kurozumi, Joji Ishida, Toshihiko Shimizu
WST-1 assay and two-chamber assay
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40a24f55abc07ab25de83aad905ad979
https://doi.org/10.1158/1535-7163.22505571
https://doi.org/10.1158/1535-7163.22505571